A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases
about
Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal healthRandomized controlled trials of interventions to prevent sexually transmitted infections: learning from the past to plan for the future.Bacterial vaginosis: a synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infectionsVaginal microbiome and sexually transmitted infections: an epidemiologic perspectiveAntimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosisThe genital econiche: focus on microbiota and bacterial vaginosisEstablishing and sustaining a healthy vaginal environment: analysis of data from a randomized trial of periodic presumptive treatment for vaginal infections.Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses.Bacterial communities of the coronal sulcus and distal urethra of adolescent males.Sexually transmitted diseases treatment guidelines, 2015.Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infectionBehavioural and medical predictors of bacterial vaginosis recurrence among female sex workers: longitudinal analysis from a randomized controlled trial.Longitudinal analysis of vaginal microbiome dynamics in women with recurrent bacterial vaginosis: recognition of the conversion process.The vaginal microbiota over an 8- to 10-year period in a cohort of HIV-infected and HIV-uninfected women.Antibacterial treatment of bacterial vaginosis: current and emerging therapiesInterventions to prevent sexually transmitted infections, including HIV infection.Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infectionThe posttrial effect of oral periodic presumptive treatment for vaginal infections on the incidence of bacterial vaginosis and Lactobacillus colonizationA Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis InfectionsRapid fluctuation of the vaginal microbiota measured by Gram stain analysis.Home Screening for Bacterial Vaginosis to Prevent Sexually Transmitted Diseases.Development and Validation of a Highly Accurate Quantitative Real-Time PCR Assay for Diagnosis of Bacterial Vaginosis.Randomized Trial of Periodic Presumptive Treatment With High-Dose Intravaginal Metronidazole and Miconazole to Prevent Vaginal Infections in HIV-negative Women.Periodic Presumptive Treatment for Vaginal Infections May Reduce the Incidence of Sexually Transmitted Bacterial Infections.Co-occurrence of Trichomonas vaginalis and bacterial vaginosis among HIV-positive women.In vitro rescue of genital strains of Chlamydia trachomatis from interferon-γ and tryptophan depletion with indole-positive, but not indole-negative Prevotella spp.Progresses in vaginal microflora physiology and implications for bacterial vaginosis and candidiasis.Vaginitis: diagnosis and management.Secnidazole: next-generation antimicrobial agent for bacterial vaginosis treatment.
P2860
Q21129223-5D2E38E2-3870-44EB-B6AC-CEC0BB1682D0Q24600011-D9CFC24C-B254-4BC8-A66F-C6EB7B26F341Q26766051-49625D60-D59D-42F6-8114-BFF95BB9D6FDQ27026086-0074D292-13B5-4817-BCC0-F6BE96B71516Q28081831-632D95F6-3441-4DE2-9335-698F27F31411Q28245116-02C113D3-D071-40A5-882B-F6F7701CA17DQ33932523-96ABFC3B-C9E1-4598-923C-138EF2614FD2Q33997785-E413A1E5-84C2-451D-A988-4B868399C5C9Q34273530-492DB7D2-BAF2-4EBE-91E1-118F2218D9E0Q34479272-3AD4848B-24A6-418A-944E-E46B76628E1CQ34645897-975111D8-4873-4727-B783-6781A42727F7Q34711359-61BA45E6-255D-4328-9686-67EAD6BC9733Q35077640-ECFB1020-E9EC-457A-BD4C-FE12E6995D72Q35078747-4E36CCF4-FAC1-448F-965D-0382FC985525Q35235235-39E450DA-199B-4893-A33A-81415E7BFC92Q35542152-824B7EB3-1231-4C9D-9F53-AF57DEF3B96FQ35681666-8F8A6AA2-358D-44F0-97D4-346303C6E1B0Q35909803-DBC40B60-1382-4C8B-8788-78985133262AQ36311615-682C439E-5952-48A7-94A5-D19BDFAE8ADAQ36501112-2C155FED-8B5E-4AE2-ACCD-BE885E920F47Q36543860-8B0FF368-2826-47F7-8825-4A97ACC14F56Q36734850-FE230072-F3D4-4A67-ACE9-E22554F8AC0AQ36812845-F67496F2-59EB-433F-80CF-01CA7F0FA340Q36931777-7811A762-2938-49EA-A6ED-BC9421DB6C54Q37206428-57ABD7C6-CDF2-4A51-917B-F332DCE399EFQ37470529-99204F84-B67C-4B13-9D0E-944B7D214C28Q37741788-4F3361DD-2CD9-4915-9F56-D1BA4288FA08Q37810417-F6741739-6D04-4959-8A26-D1B2500AFC34Q47735991-8030E4EE-559E-4773-B460-154707C7885B
P2860
A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
A randomized trial of metronid ...... sexually transmitted diseases
@ast
A randomized trial of metronid ...... sexually transmitted diseases
@en
type
label
A randomized trial of metronid ...... sexually transmitted diseases
@ast
A randomized trial of metronid ...... sexually transmitted diseases
@en
prefLabel
A randomized trial of metronid ...... sexually transmitted diseases
@ast
A randomized trial of metronid ...... sexually transmitted diseases
@en
P2860
P1476
A randomized trial of metronid ...... sexually transmitted diseases
@en
P2093
Jane R Schwebke
Renee Desmond
P2860
P304
P356
10.1016/J.AJOG.2007.02.048
P407
P577
2007-06-01T00:00:00Z